Observational studyArthritis research & therapy2015

Comparative effectiveness and safety of rituximab versus subsequent anti-tumor necrosis factor therapy in patients with rheumatoid arthritis with prior exposure to anti-tumor necrosis factor therapies in the United States Corrona registry.

Leslie R Harrold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.